Your browser doesn't support javascript.
loading
[A case of gastric endocrine cell carcinoma which was significantly reduced in size by radiotherapy].
Azakami, Kiyoshi; Nishida, Kouji; Tanikawa, Ken.
  • Azakami K; Gastroenterology, Sankoukai Miyazaki Hospital.
Nihon Ronen Igakkai Zasshi ; 53(1): 62-9, 2016.
Article en Ja | MEDLINE | ID: mdl-26935520
ABSTRACT
In 2010, the World Health Organization classified gastric neuroendocrine tumors (NETs) into three types NET grade (G) 1, NET G2 and neuroendocrine carcinoma (NEC). NECs are associated with a very poor prognosis. The patient was an 84-year-old female who was initially diagnosed by gastrointestinal endoscope with type 3 advanced gastric cancer with stenosis of the gastric cardia. Her overall status and performance status did not allow for operations or intensive chemotherapy. Palliative radiotherapy was performed and resulted in a significant reduction in the size of the tumor as well as the improvement of the obstructive symptoms. She died 9 months after radiotherapy. An autopsy provided a definitive diagnosis of gastric endocrine cell carcinoma, and the effectiveness of radiotherapy was pathologically-confirmed. Palliative radiotherapy may be a useful treatment option for providing symptom relief, especially for old patients with unresectable advanced gastric neuroendocrine carcinoma.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Carcinoma Neuroendocrino Tipo de estudio: Prognostic_studies Límite: Aged80 / Female / Humans Idioma: Ja Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Carcinoma Neuroendocrino Tipo de estudio: Prognostic_studies Límite: Aged80 / Female / Humans Idioma: Ja Año: 2016 Tipo del documento: Article